168 related articles for article (PubMed ID: 17114123)
1. Erythrocyte membrane anionic content and urinary glycosaminoglycan excretion in type 1 diabetes: association with retinopathy.
Yenice O; Kazokoğlu H; Ozcan E; Yüksel M; Adigüzel G; Haklar G; Yavuz DG
Curr Eye Res; 2006 Nov; 31(11):975-81. PubMed ID: 17114123
[TBL] [Abstract][Full Text] [Related]
2. Erytrocyte membrane anionic charge in type 2 diabetic patients with retinopathy.
Budak Y; Demirci H; Akdogan M; Yavuz D
BMC Ophthalmol; 2004 Oct; 4():14. PubMed ID: 15473902
[TBL] [Abstract][Full Text] [Related]
3. Insulin-dependent diabetes mellitus and glycosaminoglycans.
Hansen C; Irmscher AK; Kuhlemann K; Beyer J; Kahaly G
Horm Metab Res; 1995 Dec; 27(12):555-8. PubMed ID: 8750785
[TBL] [Abstract][Full Text] [Related]
4. Effects of ACE inhibition and angiotensin II receptor blockade on glomerular basement membrane protein excretion and charge selectivity in type 2 diabetic patients.
Deyneli O; Yavuz D; Velioglu A; Cacina H; Aksoy N; Haklar G; Taga Y; Akalin S
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):98-103. PubMed ID: 17083064
[TBL] [Abstract][Full Text] [Related]
5. Diabetic microangiopathy and urinary glycosaminoglycans.
Kahaly G; Hansen C; Otto E; Förster G; Beyer J; Hommel G
Exp Clin Endocrinol Diabetes; 1997; 105(3):145-51. PubMed ID: 9228510
[TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycans in urine of type 1 diabetic patients.
Sindelka G; Skrha J; Stibor V; Stolba P
Sb Lek; 1993; 94(1):77-80. PubMed ID: 7992002
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of urinary excretion of N-acetyl-beta-glucosaminidase in diabetic retinopathy].
Garbín Fuentes I ; Pérez Blanco FJ ; Pérez Chica G ; Moreno Terribas G ; Rodríguez Cuartero A ; Avilés Puigvert M
Arch Soc Esp Oftalmol; 2000 Dec; 75(12):791-5. PubMed ID: 11151274
[TBL] [Abstract][Full Text] [Related]
8. Fluidity and fatty acid components of erythrocyte membranes in diabetic retinopathy.
Yang G; Qiu H; Wang S; Deng H; Zhang S; Li L
Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):407-12. PubMed ID: 10862451
[TBL] [Abstract][Full Text] [Related]
9. Increased protein carbonylation of red blood cell membrane in diabetic retinopathy.
Margetis PI; Antonelou MH; Petropoulos IK; Margaritis LH; Papassideri IS
Exp Mol Pathol; 2009 Aug; 87(1):76-82. PubMed ID: 19379730
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
[TBL] [Abstract][Full Text] [Related]
12. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
[TBL] [Abstract][Full Text] [Related]
13. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
14. Plasma prekallikrein as a risk factor for diabetic retinopathy.
Kedzierska K; Ciechanowski K; Gołembiewska E; Safranow K; Ciechanowicz A; Domański L; Myślak M; Róźański J
Arch Med Res; 2005; 36(5):539-43. PubMed ID: 16099335
[TBL] [Abstract][Full Text] [Related]
15. Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden.
Torffvit O; Eriksson JW; Henricsson M; Sundkvist G; Arnqvist HJ; Blohmé G; Bolinder J; Nyström L; Ostman J; Svensson M
J Diabetes Complications; 2007; 21(4):246-51. PubMed ID: 17616355
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy.
Yamaguchi M; Nakamura N; Nakano K; Kitagawa Y; Shigeta H; Hasegawa G; Ienaga K; Nakamura K; Nakazawa Y; Fukui I; Obayashi H; Kondo M
Diabet Med; 1998 Jun; 15(6):458-62. PubMed ID: 9632118
[TBL] [Abstract][Full Text] [Related]
17. [Serum sialic acid, cellular anionic charge and erythrocyte aggregation in diabetic and hypertensive patients].
Lebensohn N; Re A; Carrera L; Barberena L; D'Arrigo M; Foresto P
Medicina (B Aires); 2009; 69(3):331-4. PubMed ID: 19622482
[TBL] [Abstract][Full Text] [Related]
18. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to heat-shock protein 65 and neopterin levels in patients with type 1 diabetes mellitus.
Weitgasser R; Lechleitner M; Koch T; Galvan G; Mühlmann J; Steiner K; Hoppichler F
Exp Clin Endocrinol Diabetes; 2003 May; 111(3):127-31. PubMed ID: 12784185
[TBL] [Abstract][Full Text] [Related]
20. The activity of N-acetyl-beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children.
Myśliwiec M; Zorena K; Balcerska A; Myśliwska J; Lipowski P; Raczyńska K
Clin Biochem; 2006 Aug; 39(8):851-6. PubMed ID: 16696964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
